Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation.

about

Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation.

Item

http://www.wikidata.org/entity/Q38604519

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advanced glycation end product ...... JAK2/STAT3 pathway activation.

@en

type

Item

label

Advanced glycation end product ...... JAK2/STAT3 pathway activation.

@en

prefLabel

Advanced glycation end product ...... JAK2/STAT3 pathway activation.

@en

P1476

Advanced glycation end product ...... JAK2/STAT3 pathway activation.

@en

P2093

Chang Shan

http://www.w3.org/2001/XMLSchema#string

Hao Wu

http://www.w3.org/2001/XMLSchema#string

Jing Yu

http://www.w3.org/2001/XMLSchema#string

Ke-Qin Zhang

http://www.w3.org/2001/XMLSchema#string

Qi Zhu

http://www.w3.org/2001/XMLSchema#string

Zi-Yu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation

Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment.

Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.

Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes.

Clinical practice. Nephropathy in patients with type 2 diabetes.

New targets for treatment of diabetic nephropathy: what we have learned from animal models.

IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling.

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Advanced glycation end products and the kidney.

P304

1185-1193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJMM.2017.3098

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28849106

http://www.w3.org/2001/XMLSchema#string

P932

5593472

http://www.w3.org/2001/XMLSchema#string